Posted on 7/26/17
Biogen Keeps The Growth Story Intact
Biogen's (BIIB) product portfolio continues to grow, and the future looks good as well: High capital returns and investments that are poised to generate growth in . . .
Posted on 7/26/17
Growth and Innovation Start in BioTech Labs
Wellesley, Mass., July 26, 2017 (GLOBE NEWSWIRE) -- Continuing medical research and advances are supporting a steady growth in the sale of the building block laboratory items . . .
Posted on 7/26/17
Biogen (BIIB) Q2 2017 Results - Earnings Call Transcript
Biogen, Inc. (NASDAQ:BIIB)Q2 2017 Earnings CallJuly 25, 2017 8:00 am ETExecutivesMatthew Calistri - Biogen, Inc.Michel Vounatsos - Biogen, Inc.Michael D. Ehlers, M.D., Ph.D. - Biogen, Inc.Paul . . .
Posted on 7/26/17
MyndYou Collaborates with Mass General Hospital
MyndYou is pleased to announce a research collaboration with Bradford Dickerson, MD, Department of Neurology and Bonnie Wong, PhD, Department of Psychiatry, both at Massachusetts General . . .
Posted on 7/26/17
Neon Therapeutics and Apexigen Announce Immuno-Oncology Clinical Trial Collaboration
CAMBRIDGE, Mass. & SAN CARLOS, Calif.--(BUSINESS WIRE)--Neon Therapeutics, Inc. an immuno-oncology company developing neoantigen-based therapeutic vaccines and T cell therapies to treat cancer, and Apexigen, Inc., . . .
Posted on 7/26/17
Kala Pharmaceuticals Closes IPO
WALTHAM, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of two Phase 3 product candidates, KPI-121 1.0% for the treatment . . .
Posted on 7/25/17
Vertex and Concert Pharmaceuticals Complete Asset Purchase Agreement for CTP-656
BOSTON & LEXINGTON, Mass.--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced the completion of their previously announced asset purchase . . .
Posted on 7/25/17
Patriots Star James White Visits Pediatric Patients at Boston Medical Center
James White, New England Patriots running back and hero of Super Bowl LI, today visited Boston Medical Center (BMC) and was announced as host of the . . .
Posted on 7/25/17
Circulation Raises $10.5 Million in Series A Financing
Circulation, the pioneer in on-demand non-emergency healthcare transportation, today announced it has raised $10.5 million in Series A financing
Posted on 7/25/17
Mercer Hosts Job Fairs in Greater Boston Area
NORWOOD,Mass.--(BUSINESS WIRE)--Mercer, a global consulting leader in advancing health, wealth, and careers, and a wholly-owned subsidiary of Marsh & McLennan Companies, Inc. (NYSE:MMC), is seeking to . . .
Posted on 7/25/17
Biogen Reports Record Quarterly Revenues of $3.1 Billion
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Inc. (NASDAQ: BIIB) today reported second quarter 2017 financial results, including: Total revenues of $3.1 billion, a 6% increase versus the prior year . . .
Posted on 7/25/17
Interleukin Genetics to Wind-Up and Pursue a Plan of Liquidation
WALTHAM, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc.(OTCQB:ILIU) today announced the adoption of a plan to wind-up and liquidate the Company subject to . . .
Posted on 7/25/17
Sarepta Therapeutics Announces Pricing of $325 Million Public Offering of Common Stock
CAMBRIDGE, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a U.S. commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted . . .
Posted on 7/24/17
Concert Pharmaceuticals Announces Termination of the HSR Act Waiting Period for CTP-656 Asset Purchase Agreement with Vertex
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that the U.S. Federal Trade Commission (“FTC”) has terminated the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of . . .
Posted on 7/24/17
Minerva Neurosciences Announces Departure of Directors
WALTHAM, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous . . .
Posted on 7/24/17
Concert Pharmaceuticals Announces Termination of the HSR Act Waiting Period for CTP-656 Asset Purchase Agreement with Vertex
LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that the U.S. Federal Trade Commission has terminated the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act . . .
Posted on 7/24/17
Sarepta Therapeutics Announces Proposed $250 Million Public Offering of Common Stock
CAMBRIDGE, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a U.S. commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted . . .
Posted on 7/24/17
These 5 Drugs Could Be Worth $45 Billion -- and They're Not Even on the Market Yet
$45 billion for five experimental drugs.That's how much market research firm EvaluatePharma projects the five most valuable pipeline candidates are worth right now. The firm calculated . . .
Posted on 7/24/17
Athenahealth - Beauty Is In The Eye Of The Beholder
Athenahealth (ATHN) was formed in 1997 by Jonathan Bush and Todd Park. It went public in 2007 for $18 per share and currently trades for ~$155 . . .
Posted on 7/24/17
An Interesting Chart About Berkshire Hathaway
Updated on July 21, 2017.On one of the first pages of every Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) annual report is a table that compares the company's performance . . .
Posted on 7/24/17
Warren Buffett's Best and Worst Stocks of 2017 So Far
Legendary investor Warren Buffett has led Berkshire Hathaway to whipping the market since he bought the company in 1965. Given his stock-picking acumen, a cottage industry . . .
Posted on 7/24/17
Athenahealth - Beauty Is In The Eye Of The Beholder
Athenahealth (ATHN) was formed in 1997 by Jonathan Bush and Todd Park. It went public in 2007 for $18 per share and currently trades for ~$155 . . .
Posted on 7/23/17
Peak Physical Therapy & Sports Performance Addresses Benefits of Tai Chi to Scituate Senior Center
The benefits of Tai Chi to help improve balance and prevent falls were presented during a recent program at the Scituate Senior Center facilitated by Peak . . .
Posted on 7/21/17
athenahealth, Inc. Revenue Growth Accelerated in Second Quarter
Once upon a time, athenahealth, Inc. (NASDAQ:ATHN) could do no wrong in the eyes of investors. The provider of cloud-based healthcare applications routinely announced year-over-year sales . . .
Posted on 7/21/17
CVS Health Opens Employment And Training Facility
CVS Health [NYSE:CVS] today announced the opening of the company's Talent Connect Center (TCC) to serve the Fort Bragg, NC military community. This innovative employment and . . .

